Linking the ubiquitin-proteasome pathway to chromatin remodeling/modification by nuclear receptors

Journal of Molecular Endocrinology

Volumn 34, Issue 2, 2005, Pages 281-297

  Kinyamu, H K ^a   Chen, J ^a   Archer, T K ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR; GLUCOCORTICOID RECEPTOR; HISTONE DEACETYLASE; HISTONE H1; HISTONE H2A; HISTONE H2B; HOLOENZYME; HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; REGULATOR PROTEIN; RNA POLYMERASE II; UBIQUITIN;

CATALYSIS; CELL CYCLE; CELL FUNCTION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN STRUCTURE; EUKARYOTIC CELL; EXPERIMENTATION; GENE EXPRESSION; GENE TARGETING; GENETIC CONSERVATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; MODULATION; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; CHROMATIN; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; NUCLEIC ACID CONFORMATION; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RNA POLYMERASE II; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; UBIQUITIN;

EID: 17844365062     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.1.01680     Document Type: Review

References (190)

1. Ahn SH, Kim M & Buratowski S 2004 Phosphorylation of serine 2 within the RNA polymerase II C-terminal domain couples transcription and 3′ end processing. Molecular Cell 13 67-76.
2. Altincicek B, Tenbaum SP, Dressel U, Thormeyer D, Renkawitz R & Baniahmad A 2000 Interaction of the corepressor Alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita. Journal of Biological Chemistry 275 7662-7667.
3. Apcher GS, Heink S, Zantopf D, Kloetzel PM, Schmid HP, Mayer RJ & Kruger E 2003 Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Letters 553 200-204.
4. Aravind L & Ponting CP 1998 Homologues of 26S proteasome subunits are regulators of transcription and translation. Protein Science 7 1250-1254.
5. Aravind L & Koonin EV 2000 The U box is a modified RING finger - a common domain in ubiquitination. Current Biology 10 R132-134.
6. Archer TK & Kinyamu HK 2004 Proteasome inhibition of glucocorticoid-mediated transcription: targeting elongation. Proceedings of the International 59th Harden/EMBO Conference, Meeting abstract P077, 28.
7. Baarends WM, Hoogerbrugge JW, Roest HP, Ooms M, Vreeburg J, Hoeijmakers JH & Grootegoed JA 1999 Histone ubiquitination and chromatin remodeling in mouse spermatogenesis. Developmental Biology 207 322-333.
8. Banks GC, Deterding LJ, Tomer KB & Archer TK 2001 Hormone-mediated dephosphorylation of specific histone H1 isoforms. Journal of Biological Chemistry 276 36467-36473.
9. Barsoum J, Levinger L & Varshavsky A 1982 On the chromatin structure of the amplified, transcriptionally active gene for dihydrofolate reductase in mouse cells. Journal of Biological Chemistry 257 5274-5282.
10. Beaudenon SL, Huacani MR, Wang G, McDonnell DP & Huibregtse JM 1999 Rsp5 ubiquitin-protein ligase mediates DNA damage-induced degradation of the large subunit of RNA polymerase II in Saccharomyces cerevisiae. Molecular and Cellular Biology 19 6972-6979.
11. Bech-Otschir D, Seeger M & Dubiel W 2002 The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. Journal of Cell Science 115 467-473.
12. Bhattacharjee RN, Banks GC, Trotter KW, Lee HL & Archer TK 2001 Histone H1 phosphorylation by Cdk2 selectively modulates mouse mammary tumor virus transcription through chromatin remodeling. Molecular and Cellular Biology 21 5417-5425.
13. Blagosklonny MV 2001 Do VHL and HIF-1 mirror p53 and Mdm-2? Degradation-transactivation loops of oncoproteins and tumor suppressors. Oncogene 20 395-398.
14. Blanquart C, Mansouri R, Fruchart JC, Staels B & Glineur C 2004 Different ways to regulate the PPARalpha stability. Biochemical and Biophysical Research Communications 319 663-670.
15. Bochtler M, Ditzel L, Groll M, Hartmann C & Huber R 1999 The proteasome. Annual Review of Biophysics and Biomolecular Structure 28 295-317.
16. Bregman DB, Halaban R, van Gool AJ, Henning KA, Friedberg EC & Warren SL 1996 UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. PNAS 93 11586-11590.
17. Bresnick EH, Bustin M, Marsaud V, Richard-Foy H & Hager GL 1992 The transcriptionally-active MMTV promoter is depleted of histone H1. Nucleic Acids Research 20 273-278.
18. Briggs SD, Xiao T, Sun ZW, Caldwell JA, Shabanowitz J, Hunt DF, Allis CD & Strahl BD 2002 Gene silencing: trans-histone regulatory pathway in chromatin. Nature 418 498.
19. Brzovic PS, Rajagopal P, Hoyt DW, King MC & Klevit RE 2001 Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nature Structural Biology 8 833-837.
20. Cardozo CP, Michaud C, Ost MC, Fliss AE, Yang E, Patterson C, Hall SJ & Caplan AJ 2003 C-terminal Hsp-interacting protein slows androgen receptor synthesis and reduces its rate of degradation. Archives of Biochemistry and Biophysics 410 134-140.
21. Carrabino S, Carminati E, Talarico D, Pardi R & Bianchi E 2004 Expression pattern of the JAB1/CSN5 gene during murine embryogenesis: colocalization with NEDD8. Gene Expression Patterns 4 423-431.
22. Chamovitz DA & Segal D 2001 JAB1/CSN5 and the COP9 signalosome. A complex situation. EMBO Reports 2 96-101.
23. Chang C, Gonzalez F, Rothermel B, Sun L, Johnston SA & Kodadek T 2001 The Gal4 activation domain binds Sug2 protein a proteasome component, in vivo and in vitro. Journal of Biological Chemistry 276 30956-30963.
24. Chauchereau A, Georgiakaki M, Perrin-Wolff M, Milgrom E & Loosfelt H 2000 JAB1 interacts with both the progesterone receptor and SRC-1. Journal of Biological Chemistry 275 8540-8548.
25. Chen HY, Sun JM, Zhang Y, Davie JR & Meistrich ML 1998 Ubiquitination of histone H3 in elongating spermatids of rat testes. Journal of Biological Chemistry 273 13165-13169.
26. Chiba T & Tanaka K 2004 Cullin-based ubiquitin ligase and its control by NEDD8-conjugating system. Current Protein and Peptide Science 5 177-184.
27. Ciechanover A & Schwartz AL 1998 The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death. PNAS 95 2727-2730.
28. Ciechanover A & Brundin P 2003 The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg. Neuron 40 427-446.
29. Ciechanover A, Orian A & Schwartz AL 2000 Ubiquitin-mediated proteolysis: biological regulation via destruction. Bioessays 22 442-451.
30. Collingwood TN, Urnov FD & Wolffe AP 1999 Nuclear receptors: coactivators, corepressors and chromatin remodeling in the control of transcription. Journal of Molecular Endocrinology 23 255-275.
31. Conaway JW, Shilatifard A, Dvir A & Conaway RC 2000 Control of elongation by RNA polymerase II. Trends in Biochemical Sciences 25 375-380.
32. Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J & Patterson C 2001 The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nature Cell Biology 3 93-96.
33. Corey LL, Weirich CS, Benjamin IJ & Kingston RE 2003 Localized recruitment of a chromatin-remodeling activity by an activator in vivo drives transcriptional elongation. Genes and Development 17 1392-1401.
34. Deng XW, Dubiel W, Wei N, Hofmann K, Mundt K, Colicelli J, Kato J, Naumann M, Segal D, Seeger M et al. 2000 Unified nomenclature for the COP9 signalosome and its subunits: an essential regulator of development. Trends in Genetics 16 202-203.
35. Dennis AP, Haq RU & Nawaz Z 2001 Importance of the regulation of nuclear receptor degradation. Frontiers in Bioscience 6 D954-959.
36. Deroo BJ & Archer TK 2001 Glucocorticoid receptor-mediated chromatin remodeling in vivo. Oncogene 20 3039-3046.
37. Deroo BJ, Rentsch C, Sampath S, Young J, DeFranco DB & Archer TK 2002 Proteasomal inhibition enhances glucocorticoid receptor transactivation and alters its subnuclear trafficking. Molecular and Cellular Biology 22 4113-4123.
38. Dover J, Schneider J, Tawiah-Boateng MA, Wood A, Dean K, Johnston M & Shilatifard A 2002 Methylation of histone H3 by COMPASS requires ubiquitination of histone H2B by Rad6. Journal of Biological Chemistry 277 28368-28371.
39. Dressel U, Thormeyer D, Altincicek B, Paululat A, Eggert M, Schneider S, Tenbaum SP, Renkawitz R & Baniahmad A 1999 Alien, a highly conserved protein with characteristics of a corepressor for members of the nuclear hormone receptor superfamily. Molecular and Cellular Biology 19 3383-3394.
40. Dubiel W, Ferrell K, Dumdey R, Standera S, Prehn S & Rechsteiner M 1995 Molecular cloning and expression of subunit 12: a non-MCP and non-ATPase subunit of the 26S protease. FEBS Letters 363 97-100.
41. Evans R & O'Malley B 2004 www.nursa.org. The Nuclear Receptor Signaling Atlas.
42. Ezhkova E & Tansey WP 2004 Proteasomal ATPases link ubiquitylation of historic H2B to methylation of histone H3. Molecular Cell 13 435-442.
43. Fan M, Bigsby RM & Nephew KP 2003 The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells. Molecular Endocrinology 17 356-365.
44. Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos MR, Pestell RG, Yuan F, Auborn KJ, Goldberg ID et al. 1999 BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284 1354-1356.
45. Fan Y & Skoultchi AI 2003 Genetic analysis of H1 linker histone subtypes and their functions in mice. Methods in Enzymology 377 85-107.
46. Fang S, Jensen JP, Ludwig RL, Vousden KH & Weissman AM 2000 Mdm2 is a RING finger-dependent ubiquitin protein ligase for itself and p53. Journal of Biological Chemistry 275 8945-8951.
47. Ferdous A, Gonzalez F, Sun L, Kodadek T & Johnston SA 2001 The 19S regulatory particle of the proteasome is required for efficient transcription elongation by RNA polymerase II. Molecular Cell 7 981-991.
48. Ferdous A, Kodadek T & Johnston SA 2002 A nonproteolytic function of the 19S regulatory subunit of the 26S proteasome is required for efficient activated transcription by human RNA polymerase II. Biochemistry 41 12798-12805.
49. Finley D, Tanaka K, Mann C, Feldmann H, Hochstrasser M, Vierstra R, Johnston S, Hampton R, Haber J, McCusker J et al. 1998 Unified nomenclature for subunits of the Saccharomyces cerevisiae proteasome regulatory particle. Trends in Biochemical Sciences 23 244-245.
50. Fischle W, Wang Y & Allis CD 2003a Binary switches and modification cassettes in histone biology and beyond. Nature 425 475-479.
51. Fischle W, Wang Y & Allis CD 2003b Histone and chromatin cross-talk. Current Opinion in Cell Biology 15 172-183.
52. Fletcher TM, Xiao N, Mautino G, Baumann CT, Wolford R, Warren BS & Hager GL 2002 ATP-dependent mobilization of the glucocorticoid receptor during chromatin remodeling. Molecular and Cellular Biology 22 3255-3263.
53. Fraser RA, Rossignol M, Heard DJ, Egly JM & Chambon P 1997 SUG1, a putative transcriptional mediator and subunit of the PA700 proteasome regulatory complex, is a DNA helicase. Journal of Biological Chemistry 272 7122-7126.
54. Frasor J, Stossi F, Danes JM, Komm B, Lyttle CR & Katzenellenbogen BS 2004 Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Research 64 1522-1533.
55. Fryer CJ & Archer TK 1998 Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393 88-91.
56. Georgel PT, Fletcher TM, Hager GL & Hansen JC 2003 Formation of higher-order secondary and tertiary chromatin structures by genomic mouse mammary tumor virus promoters. Genes and Development 17 1617-1629.
57. Gerber M & Shilatifard A 2003 Transcriptional elongation by RNA polymerase II and histone methylation. Journal of Biological Chemistry 278 26303-26306.
58. Gianni M, Bauer A, Garattini E, Chambon P & Rochette-Egly C 2002 Phosphorylation by p38 MAPK and recruitment of SUG-1 are required for RA-induced RAR gamma degradation and transactivation. EMBO Journal 21 3760-3769.
59. Gillette TG, Gonzalez F, Delahodde A, Johnston SA & Kodadek T 2004 Physical and functional association of RNA polymerase II and the proteasome. PNAS 101 5904-5909.
60. Glickman MH & Ciechanover A 2002 The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiological Reviews 82 373-428.
61. Glickman MH, Rubin DM, Coux O, Wefes I, Pfeifer G, Cjeka Z, Baumeister W, Fried VA & Finley D 1998 A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94 615-623.
62. Goldberg AL, Elledge SJ & Harper JW 2001 The cellular chamber of doom. Scientific American 284 68-73.
63. Goldknopf IL, Taylor CW, Baum RM, Yeoman LC, Olson MO, Prestayko AW & Busch H 1975 Isolation and characterization of protein A24, a 'histone-like' non-histone chromosomal protein. Journal of Biological Chemistry 250 7182-7187.
64. Gonzalez F, Delahodde A, Kodadek T & Johnston SA 2002 Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296 548-550.
65. Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y & Livingston DM 2003 Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300 342-344.
66. Haas AL, Reback PB & Chau V 1991 Ubiquitin conjugation by the yeast RAD6 and CDC34 gene products. Comparison to their putative rabbit homologs, E2(20K) AND E2(32K). Journal of Biological Chemistry 266 5104-5112.
67. Hager GL, Nagaich AK, Johnson TA, Walker DA & John S 2004 Dynamics of nuclear receptor movement and transcription. Biochimica et Biophysica Acta 1677 46-51.
68. Hampsey M & Reinberg D 2003 Tails of intrigue: phosphorylation of RNA polymerase II mediates histone methylation. Cell 113 429-432.
69. Harari-Steinberg O & Chamovitz DA 2004 The COP9 signalosome: mediating between kinase signaling and protein degradation. Current Protein and Peptide Science 5 185-189.
70. Hebbar PB & Archer TK 2003 Chromatin remodeling by nuclear receptors. Chromosoma 111 495-504.
71. Henry KW, Wyce A, Lo WS, Duggan LJ, Emre NC, Kao CF, Pillus L, Shilatifard A, Osley MA & Berger SL 2003 Transcriptional activation via sequential histone H2B ubiquitylation and deubiquitylation, mediated by SAGA-associated Ubp8. Genes and Development 17 2648-2663.
72. Hoang T, Fenne IS, Cook C, Borud B, Bakke M, Lien EA & Mellgren G 2004 cAMP-dependent protein kinase regulates ubiquitin-proteasome mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1. Journal of Biological Chemistry 279 49120-49130.
73. Hook SS, Orian A, Cowley SM & Eisenman RN 2002 Histone deacetylase 6 binds polyubiquitin through its zinc finger (PAZ domain) and copurifies with deubiquitinating enzymes. PNAS 99 13425-13430.
74. Hsiao PW, Deroo BJ & Archer TK 2002 Chromatin remodeling and tissue-selective responses of nuclear hormone receptors. Biochemistry and Cell Biology 80 343-351.
75. Huibregtse JM, Yang JC & Beaudenon SL 1997 The large subunit of RNA polymerase II is a substrate of the Rsp5 ubiquitin-protein ligase. PNAS 94 3656-3661.
76. Hwang WW, Venkatasubrahmanyam S, Ianculescu AG, Tong A, Boone C & Madhani HD 2003 A conserved RING finger protein required for histone H2B monoubiquitination and cell size control. Molecular Cell 11 261-266.
77. Imhof MO & McDonnell DP 1996 Yeast RSP5 and its human homolog hRPF1 potentiate hormone-dependent activation of transcription by human progesterone and glucocorticoid receptors. Molecular and Cellular Biology 16 2594-2605.
78. Ishizuka T, Satoh T, Monden T, Shibusawa N, Hoshida T, Yamada M & Movi M 2001 Human immunodeficiency virus type I Tat binding protein-1 is a transcriptional coactivator specific for TR. Molecular Endocrinology 15 1329-1343.
79. Ismaili N & Garabedian MJ 2004 Modulation of glucocorticoid receptor function via phosphorylation. Annals of the New York Academy of Sciences 1024 86-101.
80. Jackson PK, Eldridge AG, Freed E, Furstenthal L, Hsu JY, Kaiser BK & Reimann JD 2000 The lore of the RINGs: substrate recognition and catalysis by ubiquitin ligases. Trends in Cell Biology 10 429-439.
81. Jason LJ, Moore SC, Lewis JD, Lindsey G & Ausio J 2002 Histone ubiquitination: a tagging tail unfolds? Bioessays 24 166-174.
82. Joazeiro CA & Weissman AM 2000 RING finger proteins: mediators of ubiquitin ligase activity. Cell 102 549-552.
83. Kang Z, Pirskanen A, Janne OA & Palvimo JJ 2002 Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. Journal of Biological Chemistry 277 48366-48371.
84. Kawaguchi Y, Kovacs JJ, McLaurin A, Vance JM, Ito A & Yao TP 2003 The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell 115 727-738.
85. Kim J, Jia L, Tilley WD & Coetzee GA 2003 Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor. Nucleic Acids Research 31 6741-6747.
86. Kinyamu HK & Archer TK 2003 Estrogen receptor-dependent proteasomal degradation of the glucccorticoid receptor is coupled to an increase in mdm2 protein expression. Molecular and Cellular Biology 23 5867-5881.
87. Kinyamu HK & Archer TK 2004 Modifying chromatin to permit steroid hormone receptor-dependent transcription. Biochimica et Biophysica Acta 1677 30-45.
88. Kisselev AF & Goldberg AL 2001 Proteasome inhibitors: from research tools to drug candidates. Chemistry and Biology 8 739-758.
89. Kitagawa H, Fujiki R, Yoshimura K, Mezaki Y, Uematsu Y, Matsui D, Ogawa S, Unno K, Okubo M, Tokita A et al. 2003 The chromatin-remodeling complex WINAC targets a nuclear receptor to promoters and is impaired in Williams syndrome. Cell 113 905-917.
90. Komarnitsky P, Cho EJ & Buratowski S 2000 Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes and Development 14 2452-2460.
91. Kopf E, Plassat JL, Vivat V, de The H, Chambon P & Rochette-Egly C 2000 Dimerization with retinoid X receptors and phosphorylation modulate the retinoic acid-induced degradation of retinoic acid receptors alpha and gamma through the ubiquitin-proteasome pathway. Journal of Biological Chemistry 275 33280-33288.
92. Kouzarides T 2002 Histone methylation in transcriptional control. Current Opinion in Genetics and Development 12 198-209.
93. Krogan NJ, Dover J, Wood A, Schneider J, Heidt J, Boateng MA, Dean K, Ryan OW, Golshani A, Johnston M et al. 2003 The Paf1 complex is required for histone H3 methylation by COMPASS and Dot1p: linking transcriptional elongation to histone methylation. Molecular Cell 11 721-729.
94. Lange CA, Shen T & Horwitz KB 2000 Phosphorylation of human progesterone receptors at serine-294 by mitogen-activated protein kinase signals: their degradation by the 26S proteasome. PNAS 97 1032-1037.
95. Lee HL & Archer TK 1998 Prolonged glucocorticoid exposure dephosphorylates historic H1 and inactivates the MMTV promoter. EMBO Journal 17 1454-1466.
96. Lee JW, Ryan F, Swaffield JC, Johnston SA & Moore DD 1995 Interaction of thyroid-hormone receptor with a conserved transcriptional mediator. Nature 374 91-94.
97. LeRoy G, Loyola A, Lane WS & Reinberg D 2000 Purification and characterization of a human factor that assembles and remodels chromatin. Journal of Biological Chemistry 275 14787-14790.
98. Levinger L & Varshavsky A 1982 Selective arrangement of ubiquitinated and D1 protein-containing nucleosomes within the Drosophila genome. Cell 28 375-385.
99. Li J, Lin Q, Yoon HG, Huang ZQ, Strahl BD, Allis CD & Wong J 2002 Involvement of histone methylation and phosphorylation in regulation of transcription by thyroid hormone receptor. Molecular and Cellular Biology 22 5688-5697.
100. Li X, Wong J, Tsai SY, Tsai MJ & O'Malley BW 2003 Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Molecular and Cellular Biology 23 3763-3773.
101. Liang G, Lin JC, Wei V, Yoo C, Cheng JC, Nguyen CT, Weisenberger DJ, Egger G, Takai D, Gonzales FA et al. 2004 Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome. PNAS 101 7357-7362.
102. Lin HK, Wang L, Hu YC, Altuwaijri S & Chang C 2002 Phosphorylation-dependent ubiquitylation and degradation of androgen receptor by Akt require Mdm2 E3 ligase. EMBO Journal 21 4037-4048.
103. Lin Q, Inselman A, Han X, Xu H, Zhang W, Handel MA & Skoultchi AI 2004 Reductions in linker histone levels are tolerated in developing spermatocytes but cause changes in specific gene expression. Journal of Biological Chemistry 279 23525-23535.
104. Lipford JR & Deshaies RJ 2003 Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation. Nature Cell Biology 5 845-850.
105. Lonard DM, Nawaz Z, Smith CL & O'Malley BW 2000 The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Molecular Cell 5 939-948.
106. Lonard DM, Tsai SY & O'Malley BW 2004 Selective estrogen receptor modulators 4-hydroxytamoxifen and raloxifene impact the stability and function of SRC-1 and SRC-3 coactivator proteins. Molecular and Cellular Biology 24 14-24.
107. Luger K, Rechsteiner TJ, Flaus AJ, Waye MM & Richmond TJ 1997 Characterization of nucleosome core particles containing histone proteins made in bacteria. Journal of Molecular Biology 272 301-311.
108. Ma H, Baumann CT, Li H, Strahl BD, Rice R, Jelinek MA, Aswad DW, Allis CD, Hager GL & Stallcup MR 2001 Hormone-dependent, CARM1-directed, arginine-specific methylation of historic H3 on a steroid-regulated promoter. Current Biology 11 1981-1985.
109. McKenna NJ & O'Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108 465-474.
110. Maglich JM, Sluder A, Guan X, Shi Y, McKee DD, Carrick K, Kamdar K, Willson TM & Moore JT 2001 Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biology 2 RESEARCH0029.
111. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P et al. 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839.
112. Mason PB & Struhl K 2003 The FACT complex travels with elongating RNA polymerase II and is important for the fidelity of transcriptional initiation in vivo. Molecular and Cellular Biology 23 8323-8333.
113. Masuyama H & Hiramatsu Y 2003 Involvement of suppressor for Gal-1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors. Journal of Biological Chemistry.
114. Meek DW 1999 Mechanisms of switching on p53: a role for covalent modification? Oncogene 18 7666-7675.
115. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M & Gannon F 2003 Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115 751-763.
116. Minsky N & Oren M 2003 Mdm2 is a E3 ubiquitin-ligase for histone H2B. Second International Mdm2 Workshop, Meeting abstract 54.
117. Mitsui A & Sharp PA 1999 Ubiquitination of RNA polymerase II large subunit signaled by phosphorylation of carboxyl-terminal domain. PNAS 96 6054-6059.
118. Molinari E, Gilman M & Natesan S 1999 Proteasome-mediated degradation of transcriptional activators correlates with activation domain potency in vivo. EMBO Journal 18 6439-6447.
119. Morillon A, Karabetsou N, O'Sullivan J, Kent N, Proudfoot N & Mellor J 2003 Isw1 chromatin remodeling ATPase coordinates transcription elongation and termination by RNA polymerase II. Cell 115 425-435.
120. Muller WG, Walker D, Hager GL & McNally JG 2001 Large-scale chromatin decondensation and recondensation regulated by transcription from a natural promoter. Journal of Cell Biology 154 33-48.
121. Muratani M & Tansey WP 2003 How the ubiquitin-proteasome system controls transcription. Nature Reviews. Molecular Cell Biology 4 192-201.
122. Narlikar GJ, Fan HY & Kingston RE 2002 Cooperation between complexes that regulate chromatin structure and transcription. Cell 108 475-487.
123. Nathan D, Sterner DE & Berger SL 2003 Histone modifications: now summoning sumoylation. PNAS 100 13118-13120.
124. Nawaz Z & O'Malley BW 2004 Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Molecular Endocrinology 18 493-499.
125. Nawaz Z, Lonard DM, Dennis AP, Smith CL & O'Malley BW 1999 Proteasome-dependent degradation of the human estrogen receptor. PNAS 96 1858-1862.
126. Nelbock P, Dillon PJ, Perkins A & Rosen CA 1990 A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator. Science 248 1650-1653.
127. Ng HH, Dole S & Struhl K 2003 The Rtf1 component of the Paf1 transcriptional elongation complex is required for ubiquitination of histone H2B. Journal of Biological Chemistry 278 33625-33628.
128. Ohta T & Fukuda M 2004 Ubiquitin and breast cancer. Oncogene 23 2079-2088.
129. Orphanides G, Wu WH, Lane WS, Hampsey M & Reinberg D 1999 The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins. Nature 400 284-288.
130. Osley MA 2004 H2B ubiquitylation: the end is in sight. Biochimica et Biophysica Acta 1677 74-78.
131. Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup, MR, Press MF & Coetzee GA 2000 Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. Cancer Research 60 5946-5949.
132. Patterson C 2002 A new gun in town: the U box is a ubiquitin ligase domain. Science's STKE: Signal Transduction Knowledge Environment 2002 PE4.
133. Perissi V, Aggarwal A, Glass CK, Rose DW & Rosenfeld MG 2004 A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116 511-526.
134. Peters JM 1998 SCF and APC: the Yin and Yang of cell cycle regulated proteolysis. Current Opinion in Cell Biology 10 759-768.
135. Pham AD & Sauer F 2000 Ubiquidn-activating/conjugating activity of TAFII250, a mediator of activation of gene expression in Drosophila. Science 289 2357-2360.
136. Pickart CM 2004 Back to the future with ubiquitin. Cell 116 181-190.
137. Poukka H, Aarnisalo P, Karvonen U, Palvimo JJ & Janne OA 1999 Ubc9 interacts with the androgen receptor and activates receptor-dependent transcription. Journal of Biological Chemistry 274 19441-19446.
138. Poukka H, Karvonen U, Janne OA & Palvimo JJ 2000 Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1). PNAS 97 14145-14150.
139. Privalsky ML 2004 The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annual Review of Physiology 66 315-360.
140. Rechsteiner M, Realini C & Ustrell V 2000 The proteasome activator 11 S REG (PA28) and class I antigen presentation. Biochemical Journal 345 1-15.
141. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J & Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Molecular Cell 11 695-707.
142. Robinson-Rechavi M, Carpentier AS, Duffraisse M & Laudet V 2001 How many nuclear hormone receptors are there in the human genome? Trends in Genetics 17 554-556.
143. Roeder RG 1996 The role of general initiation factors in transcription by RNA polymerase II. Trends in Biochemical Sciences 21 327-335.
144. Roest HP, van Klaveren J, de Wit J, van Gurp CG, Koken MH, Vermey M, van Roijen JH, Hoogerbrugge JW, Vreeburg JT, Baarends WM et al. 1996 Inactivation of the HR6B ubiquitin-conjugating DNA repair enzyme in mice causes male sterility associated with chromatin modification. Cell 86 799-810.
145. Roest HP, Baarends WM, de Wit J, van Klaveren JW, Wassenaar E, Hoogerbrugge JW, van Cappellen WA, Hoeijmakers JH & Grootegoed JA 2004 The ubiquitin-conjugating DNA repair enzyme HR6A is a maternal factor essential for early embryonic development in mice. Molecular and Cellular Biology 24 5485-5495.
146. Saji S, Okumura N, Eguchi H, Nakashima S, Suzuki A, Toi M, Nozawa Y & Hayashi S 2001 MDM2 enhances the function of estrogen receptor alpha in human breast cancer cells. Biochemical and Biophysical Research Communications 281 259-265.
147. Salghetti SE, Muratani M, Wijnen H, Futcher B & Tansey WP 2000 Functional overlap of sequences that activate transcription and signal ubiquitin-mediated proteolysis. PNAS 97 3118-3123.
148. Salghetti SE, Caudy AA, Chenoweth JG & Tansey WP 2001 Regulation of transcriptional activation domain function by ubiquitin. Science 293 1651-1653.
149. Salvat C, Aquaviva C, Jariel-Encontre I, Ferrara P, Pariat M, Steff AM, Carillo S & Piechaczyk M 1999 Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Molecular Biology Reports 26 45-51.
150. Santos-Rosa H, Schneider R, Bernstein BE, Karabetsou N, Morillon A, Weise C, Schreiber SL, Mellor J & Kouzarides T 2003 Methylation of histone H3 K4 mediates association of the Isw1p ATPase with chromatin. Molecular Cell 12 1325-1332.
151. Saunders A, Werner J, Andrulis ED, Nakayama T, Hirose S, Reinberg D & Lis JT 2003 Tracking FACT and the RNA polymerase II elongation complex through chromatin in vivo. Science 301 1094-1096.
152. Schaaf MJ & Cidlowski JA 2003 Molecular determinants of glucocorticoid receptor mobility in living cells: the importance of ligand affinity. Molecular and Cellular Biology 23 1922-1934.
153. Scheffner M 1998 Ubiquitin, E6-AP, and their role in p53 inactivation. Pharmacology and Therapeutics 78 129-139.
154. Schneider R, Bannister AJ, Myers FA, Thorne AW, Crane-Robinson C & Kouzarides T 2004 Histone H3 lysine 4 methylation patterns in higher eukaryotic genes. Nature Cell Biology 6 73-77.
155. Schwartz AL & Ciechanover A 1999 The ubiquitin-proteasome pathway and pathogenesis of human diseases. Annual Review of Medicine 50 57-74.
156. Schwechheimer C & Deng XW 2001 COP9 signalosome revisited: a novel mediator of protein degradation. Trends in Cell Biology 11 420-426.
157. Sedkov Y, Cho E, Petruk S, Cherbas L, Smith ST, Jones RS, Cherbas P, Canaani E, Jaynes JB & Mazo A 2003 Methylation at lysine 4 of histone H 3 in ecdysone-dependent development of Drosophila. Nature 426 78-83.
158. Sengupta S & Wasylyk B 2001 Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2. Genes and Development 15 2367-2380.
159. Shang Y, Hu X, DiRenzo J, Lazar MA & Brown M 2000 Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 843-852.
160. Shao W, Keeton EK, McDonnell DP & Brown M 2004 Coactivator AIB1 links estrogen receptor transcriptional activity and stability. PNAS 101 11599-11604.
161. Shen T, Horwitz KB & Lange CA 2001 Transcriptional hyperactivity of human progesterone receptors is coupled to their ligand-dependent down-regulation by mitogen-activated protein kinase-dependent phosphorylation of serine 294. Molecular and Cellular Biology 21 6122-6131.
162. Shilatifard A, Conaway RC & Conaway JW 2003 The RNA polymerase II elongation complex. Annual Review of Biochemistry 72 693-715.
163. Smith CL, DeVera DG, Lamb DJ, Nawaz Z, Jiang YH, Beaudet AL & O'Malley BW 2002 Genetic ablation of the steroid receptor coactivator-ubiquitin ligase, E6-AP, results in tissue-selective steroid hormone resistance and defects in reproduction. Molecular and Cellular Biology 22 525-535.
164. Stallcup MR, Kim JH, Teyssier C, Lee YH, Ma H & Chen D 2003 The roles of protein-protein interactions and protein methylation in transcriptional activation by nuclear receptors and their coactivators. Journal of Steroid Biochemistry and Molecular Biology 85 139-145.
165. Stavreva DA, Muller WG, Hager GL, Smith CL & McNally JG 2004 Rapid glucocorticoid receptor exchange at a promoter is coupled to transcription and regulated by chaperones and proteasomes. Molecular and Cellular Biology 24 2682-2697.
166. Stenoien DL, Patel K, Mancini MG, Dutertre M, Smith CL, O'Malley BW & Mancini MA 2001 FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nature Cell Biology 3 15-23.
167. Stoner M, Saville B, Wormke M, Dean D, Burghardt R & Safe S 2002 Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Molecular Endocrinology 16 2231-2242.
168. Sun L, Johnston SA & Kodadek T 2002 Physical association of the APIS complex and general transcription factors. Biochemical and Biophysical Research Communications 296 991-999.
169. Sun ZW & Allis CD 2002 Ubiquitination of histone H2B regulates H3 methylation and gene silencing in yeast. Nature 418 104-108.
170. Swaffield JC, Melcher K & Johnston SA 1995 A highly conserved ATPase protein as a mediator between acidic activation domains and the TATA-binding protein. Nature 374 88-91.
171. Thorne AW, Sautiere P, Briand G & Crane-Robinson C 1987 The structure of ubiquitinated histone H2B. EMBO Journal 6 1005-1010.
172. Turner SD, Ricci AR, Petropoulos H, Genereaux J, Skerjanc IS & Brandl CJ 2002 The E2 ubiquitin conjugase Rad6 is required for the ArgR/Mcm1 repression of ARG1 transcription. Molecular and Cellular Biology 22 4011-4019.
173. Tyers M & Jorgensen P 2000 Proteolysis and the cell cycle: with this RING I do thee destroy. Current Opinion in Genetics and Development 10 54-64.
174. Ulrich HD 2002 Degradation or maintenance: actions of the ubiquitin system on eukaryotic chromatin. Eukaryotic Cell 1 1-10.
175. Voges D, Zwickl P & Baumeister W 1999 The 26S proteasome: a molecular machine designed for controlled proteolysis. Annual Review of Biochemistry 68 1015-1068.
176. von Arnim AG 2003 On again-off again: COP9 signalosome turns the key on protein degradation. Current Opinion in Plant Biology 6 520-529.
177. Wallace AD & Cidlowski JA 2001 Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. Journal of Biological Chemistry 276 42714-42721.
178. Webster JC, Jewell CM, Bodwell JE, Munck A, Sar M & Cidlowski JA 1997 Mouse glucocorticoid receptor phosphorylation status influences multiple functions of the receptor protein. Journal of Biological Chemistry 272 9287-9293.
179. Weeda G, Rossignol M, Fraser RA, Winkler GS, Vermeulen W, van 't Veer LJ, Ma L, Hoeijmakers JH & Egly JM 1997 The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor. Nucleic Acids Research 25 2274-2283.
180. Wei N & Deng XW 2003 The COP9 signalosome. Annual Review of Cell and Developmental Biology 19 261-286.
181. Wei N, Chamovitz DA & Deng XW 1994 Arabidopsis COP9 is a component of a novel signaling complex mediating light control of development. Cell 78 117-124.
182. Wijayaratne AL & McDonnell DP 2001 The human estrogen receptor alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. Journal of Biological Chemistry 276 35684-35692.
183. Wolffe AP & Hayes JJ 1999 Chromatin disruption and modification. Nucleic Acids Research 27 711-720.
184. Wong BR, Parlati F, Qu K, Demo S, Pray T, Huang J, Payan DG & Bennett MK 2003 Drug discovery in the ubiquitin regulatory pathway. Drug Discovery Today 8 746-754.
185. Wood A, Krogan NJ, Dover J, Schneider J, Heidt J, Boateng MA, Dean K, Golshani A, Zhang Y, Greenblatt JF et al. 2003 Bre1, an E3 ubiquitin ligase required for recruitment and substrate selection of Rad6 at a promoter. Molecular Cell 11 267-274.
186. Wormke M, Stoner M, Saville B, Walker K, Abdelrahim M, Burghardt R & Safe S 2003 The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes. Molecular and Cellular Biology 23 1843-1855.
187. Xiao B, Wilson JR & Gamblin SJ 2003 SET domains and histone methylation. Current Opinion in Structural Biology 13 699-705.
188. Yan F, Gao X, Lonard DM & Nawaz Z 2003 Specific ubiquitin-conjugating enzymes promote degradation of specific nuclear receptor coactivators. Molecular Endocrinology 17 1315-1331.
189. Zhang X, Jeyakumar M, Petukhov S & Bagchi MK 1998 A nuclear receptor corepressor modulates transcriptional activity of antagonist-occupied steroid hormone receptor. Molecular Endocrinology 12 513-524.
190. Zhang Y 2003 Transcriptional regulation by histone ubiquitination and deubiquitination. Genes and Development 17 2733-2740.